Use  ||| S:0 E:4 ||| NN
of  ||| S:4 E:7 ||| IN
biochemical  ||| S:7 E:19 ||| JJ
parameters  ||| S:19 E:30 ||| NNS
to  ||| S:30 E:33 ||| TO
predict  ||| S:33 E:41 ||| VB
metabolic  ||| S:41 E:51 ||| JJ
elimination  ||| S:51 E:63 ||| NN
in  ||| S:63 E:66 ||| IN
endurance  ||| S:66 E:76 ||| JJ
rides  ||| S:76 E:82 ||| NNS
Endurance  ||| S:82 E:92 ||| JJ
races  ||| S:92 E:98 ||| NNS
are  ||| S:98 E:102 ||| VBP
the  ||| S:102 E:106 ||| DT
competition  ||| S:106 E:118 ||| NN
with  ||| S:118 E:123 ||| IN
the  ||| S:123 E:127 ||| DT
biggest  ||| S:127 E:135 ||| JJS
metabolic  ||| S:135 E:145 ||| JJ
demands  ||| S:145 E:153 ||| NNS
for  ||| S:153 E:157 ||| IN
the  ||| S:157 E:161 ||| DT
sport  ||| S:161 E:167 ||| NN
horse ||| S:167 E:172 ||| NN
.  ||| S:172 E:174 ||| .
During  ||| S:174 E:181 ||| IN
races ||| S:181 E:186 ||| NNS
,  ||| S:186 E:188 ||| ,
some  ||| S:188 E:193 ||| DT
horses  ||| S:193 E:200 ||| NNS
show  ||| S:200 E:205 ||| VBP
homeostasis  ||| S:205 E:217 ||| JJ
alterations ||| S:217 E:228 ||| NN
,  ||| S:228 E:230 ||| ,
having  ||| S:230 E:237 ||| VBG
repercussions  ||| S:237 E:251 ||| NNS
in  ||| S:251 E:254 ||| IN
diverse  ||| S:254 E:262 ||| JJ
biochemical  ||| S:262 E:274 ||| JJ
parameters  ||| S:274 E:285 ||| NNS
and  ||| S:285 E:289 ||| CC
negative  ||| S:289 E:298 ||| JJ
consequences  ||| S:298 E:311 ||| NNS
on  ||| S:311 E:314 ||| IN
performance  ||| S:314 E:326 ||| NN
and  ||| S:326 E:330 ||| CC
health ||| S:330 E:336 ||| NN
.  ||| S:336 E:338 ||| .
To  ||| S:338 E:341 ||| TO
evaluate  ||| S:341 E:350 ||| VB
the  ||| S:350 E:354 ||| DT
utility  ||| S:354 E:362 ||| NN
of  ||| S:362 E:365 ||| IN
biochemical  ||| S:365 E:377 ||| JJ
analysis  ||| S:377 E:386 ||| NN
in  ||| S:386 E:389 ||| IN
the  ||| S:389 E:393 ||| DT
early  ||| S:393 E:399 ||| JJ
diagnosis  ||| S:399 E:409 ||| NN
of  ||| S:409 E:412 ||| IN
metabolic  ||| S:412 E:422 ||| JJ
stress  ||| S:422 E:429 ||| NN
and  ||| S:429 E:433 ||| CC
to  ||| S:433 E:436 ||| TO
determine  ||| S:436 E:446 ||| VB
cut-off  ||| S:446 E:454 ||| JJ
values  ||| S:454 E:461 ||| NNS
of  ||| S:461 E:464 ||| IN
biochemical  ||| S:464 E:476 ||| JJ
parameters  ||| S:476 E:487 ||| NNS
to  ||| S:487 E:490 ||| TO
assist  ||| S:490 E:497 ||| VB
in  ||| S:497 E:500 ||| IN
the  ||| S:500 E:504 ||| DT
prevention  ||| S:504 E:515 ||| NN
of  ||| S:515 E:518 ||| IN
metabolic  ||| S:518 E:528 ||| JJ
alterations  ||| S:528 E:540 ||| NN
in  ||| S:540 E:543 ||| IN
endurance  ||| S:543 E:553 ||| JJ
horses ||| S:553 E:559 ||| NNS
.  ||| S:559 E:561 ||| .
This  ||| S:561 E:566 ||| DT
study  ||| S:566 E:572 ||| NN
involved  ||| S:572 E:581 ||| VBD
36  ||| S:581 E:584 ||| CD
CEI  ||| S:584 E:588 ||| NN
races  ||| S:588 E:594 ||| NNS
and  ||| S:594 E:598 ||| CC
283  ||| S:598 E:602 ||| CD
horses  ||| S:602 E:609 ||| NNS
( ||| S:609 E:610 ||| -LRB-
41  ||| S:610 E:613 ||| CD
eliminated  ||| S:613 E:624 ||| VBN
because  ||| S:624 E:632 ||| IN
of  ||| S:632 E:635 ||| IN
metabolic  ||| S:635 E:645 ||| JJ
disturbances ||| S:645 E:657 ||| NNS
) ||| S:657 E:658 ||| -RRB-
.  ||| S:658 E:660 ||| .
Blood  ||| S:660 E:666 ||| NN
samples  ||| S:666 E:674 ||| NNS
were  ||| S:674 E:679 ||| VBD
taken  ||| S:679 E:685 ||| VBN
before  ||| S:685 E:692 ||| IN
competition ||| S:692 E:703 ||| NN
,  ||| S:703 E:705 ||| ,
after  ||| S:705 E:711 ||| IN
the  ||| S:711 E:715 ||| DT
vet-gates  ||| S:715 E:725 ||| JJ
and  ||| S:725 E:729 ||| CC
after  ||| S:729 E:735 ||| IN
finishing  ||| S:735 E:745 ||| VBG
the  ||| S:745 E:749 ||| DT
race  ||| S:749 E:754 ||| NN
or  ||| S:754 E:757 ||| CC
veterinary  ||| S:757 E:768 ||| JJ
disqualification ||| S:768 E:784 ||| NN
.  ||| S:784 E:786 ||| .
Packed  ||| S:786 E:793 ||| JJ
cell  ||| S:793 E:798 ||| NN
volume  ||| S:798 E:805 ||| NN
( ||| S:805 E:806 ||| -LRB-
PCV ||| S:806 E:809 ||| NNP
) ||| S:809 E:810 ||| -RRB-
,  ||| S:810 E:812 ||| ,
activities  ||| S:812 E:823 ||| NNS
of  ||| S:823 E:826 ||| IN
CK ||| S:826 E:828 ||| NNP
,  ||| S:828 E:830 ||| ,
AST  ||| S:830 E:834 ||| NNP
and  ||| S:834 E:838 ||| CC
LDH ||| S:838 E:841 ||| NNP
,  ||| S:841 E:843 ||| ,
and  ||| S:843 E:847 ||| CC
concentrations  ||| S:847 E:862 ||| NNS
of  ||| S:862 E:865 ||| IN
total  ||| S:865 E:871 ||| JJ
plasma  ||| S:871 E:878 ||| NN
proteins  ||| S:878 E:887 ||| NNS
( ||| S:887 E:888 ||| -LRB-
PP ||| S:888 E:890 ||| NNP
) ||| S:890 E:891 ||| -RRB-
,  ||| S:891 E:893 ||| ,
urea ||| S:893 E:897 ||| NN
,  ||| S:897 E:899 ||| ,
creatinine  ||| S:899 E:910 ||| NNS
( ||| S:910 E:911 ||| -LRB-
Cr ||| S:911 E:913 ||| NNP
) ||| S:913 E:914 ||| -RRB-
,  ||| S:914 E:916 ||| ,
uric  ||| S:916 E:921 ||| JJ
acid  ||| S:921 E:926 ||| NN
( ||| S:926 E:927 ||| -LRB-
UA ||| S:927 E:929 ||| NNP
)  ||| S:929 E:931 ||| -RRB-
and  ||| S:931 E:935 ||| CC
plasma  ||| S:935 E:942 ||| JJ
lactate  ||| S:942 E:950 ||| NN
were  ||| S:950 E:955 ||| VBD
determined ||| S:955 E:965 ||| VBN
.  ||| S:965 E:967 ||| .
Successful  ||| S:967 E:978 ||| JJ
horses  ||| S:978 E:985 ||| NNS
were  ||| S:985 E:990 ||| VBD
compared  ||| S:990 E:999 ||| VBN
with  ||| S:999 E:1004 ||| IN
horses  ||| S:1004 E:1011 ||| NNS
eliminated  ||| S:1011 E:1022 ||| VBD
due  ||| S:1022 E:1026 ||| JJ
to  ||| S:1026 E:1029 ||| TO
metabolic  ||| S:1029 E:1039 ||| VB
conditions  ||| S:1039 E:1050 ||| NNS
in  ||| S:1050 E:1053 ||| IN
the  ||| S:1053 E:1057 ||| DT
values  ||| S:1057 E:1064 ||| NNS
obtained  ||| S:1064 E:1073 ||| VBN
in  ||| S:1073 E:1076 ||| IN
the  ||| S:1076 E:1080 ||| DT
phase  ||| S:1080 E:1086 ||| NN
prior  ||| S:1086 E:1092 ||| RB
to  ||| S:1092 E:1095 ||| TO
being  ||| S:1095 E:1101 ||| VBG
removed  ||| S:1101 E:1109 ||| VBN
from  ||| S:1109 E:1114 ||| IN
the  ||| S:1114 E:1118 ||| DT
competition ||| S:1118 E:1129 ||| NN
.  ||| S:1129 E:1131 ||| .
Factors  ||| S:1131 E:1139 ||| NNS
associated  ||| S:1139 E:1150 ||| VBN
with  ||| S:1150 E:1155 ||| IN
metabolic  ||| S:1155 E:1165 ||| JJ
elimination  ||| S:1165 E:1177 ||| NN
were  ||| S:1177 E:1182 ||| VBD
further  ||| S:1182 E:1190 ||| RB
analysed  ||| S:1190 E:1199 ||| VBP
using  ||| S:1199 E:1205 ||| VBG
multiple  ||| S:1205 E:1214 ||| JJ
logistic  ||| S:1214 E:1223 ||| JJ
regression  ||| S:1223 E:1234 ||| JJ
analysis ||| S:1234 E:1242 ||| NN
.  ||| S:1242 E:1244 ||| .
Dichotomisation  ||| S:1244 E:1260 ||| NNP
for  ||| S:1260 E:1264 ||| IN
each  ||| S:1264 E:1269 ||| DT
variable  ||| S:1269 E:1278 ||| NN
was  ||| S:1278 E:1282 ||| VBD
made  ||| S:1282 E:1287 ||| VBN
using  ||| S:1287 E:1293 ||| VBG
the  ||| S:1293 E:1297 ||| DT
receiver-operating  ||| S:1297 E:1316 ||| JJ
characteristic  ||| S:1316 E:1331 ||| JJ
curve  ||| S:1331 E:1337 ||| NN
to  ||| S:1337 E:1340 ||| TO
enter  ||| S:1340 E:1346 ||| VB
into  ||| S:1346 E:1351 ||| IN
the  ||| S:1351 E:1355 ||| DT
model ||| S:1355 E:1360 ||| NN
.  ||| S:1360 E:1362 ||| .
PCV  ||| S:1362 E:1366 ||| NNP
>  ||| S:1366 E:1368 ||| CD
52 ||| S:1368 E:1370 ||| CD
% ||| S:1370 E:1371 ||| NN
,  ||| S:1371 E:1373 ||| ,
PP  ||| S:1373 E:1376 ||| NNP
>  ||| S:1376 E:1378 ||| CD
82  ||| S:1378 E:1381 ||| CD
g ||| S:1381 E:1382 ||| CD
/ ||| S:1382 E:1383 ||| CD
l ||| S:1383 E:1384 ||| NN
,  ||| S:1384 E:1386 ||| ,
standardised  ||| S:1386 E:1399 ||| VBG
Cr  ||| S:1399 E:1402 ||| NNP
>  ||| S:1402 E:1404 ||| CD
30  ||| S:1404 E:1407 ||| CD
mg ||| S:1407 E:1409 ||| CD
/ ||| S:1409 E:1410 ||| CD
l  ||| S:1410 E:1412 ||| CD
100  ||| S:1412 E:1416 ||| CD
km ||| S:1416 E:1418 ||| NN
,  ||| S:1418 E:1420 ||| ,
UA  ||| S:1420 E:1423 ||| NNP
>  ||| S:1423 E:1425 ||| CD
72  ||| S:1425 E:1428 ||| CD
mg ||| S:1428 E:1430 ||| CD
/ ||| S:1430 E:1431 ||| CD
l ||| S:1431 E:1432 ||| NN
,  ||| S:1432 E:1434 ||| ,
standardised  ||| S:1434 E:1447 ||| FW
CK  ||| S:1447 E:1450 ||| FW
>  ||| S:1450 E:1452 ||| FW
12.6  ||| S:1452 E:1457 ||| FW
ui ||| S:1457 E:1459 ||| FW
/ ||| S:1459 E:1460 ||| FW
l  ||| S:1460 E:1462 ||| FW
km  ||| S:1462 E:1465 ||| FW
and  ||| S:1465 E:1469 ||| CC
standardised  ||| S:1469 E:1482 ||| JJ
AST  ||| S:1482 E:1486 ||| NNP
>  ||| S:1486 E:1488 ||| CD
6.2  ||| S:1488 E:1492 ||| CD
ui ||| S:1492 E:1494 ||| CD
/ ||| S:1494 E:1495 ||| CD
l  ||| S:1495 E:1497 ||| CD
km  ||| S:1497 E:1500 ||| NNS
were  ||| S:1500 E:1505 ||| VBD
associated  ||| S:1505 E:1516 ||| VBN
with  ||| S:1516 E:1521 ||| IN
the  ||| S:1521 E:1525 ||| DT
development  ||| S:1525 E:1537 ||| NN
of  ||| S:1537 E:1540 ||| IN
metabolic  ||| S:1540 E:1550 ||| JJ
alterations ||| S:1550 E:1561 ||| NN
.  ||| S:1561 E:1563 ||| .
Of  ||| S:1563 E:1566 ||| IN
the  ||| S:1566 E:1570 ||| DT
horses  ||| S:1570 E:1577 ||| NNS
with  ||| S:1577 E:1582 ||| IN
an  ||| S:1582 E:1585 ||| DT
imbalance  ||| S:1585 E:1595 ||| NN
between  ||| S:1595 E:1603 ||| IN
PCV  ||| S:1603 E:1607 ||| NNP
and  ||| S:1607 E:1611 ||| CC
PP ||| S:1611 E:1613 ||| NNP
,  ||| S:1613 E:1615 ||| ,
30 ||| S:1615 E:1617 ||| CD
%  ||| S:1617 E:1619 ||| NN
had  ||| S:1619 E:1623 ||| VBD
metabolic  ||| S:1623 E:1633 ||| JJ
elimination  ||| S:1633 E:1645 ||| NN
in  ||| S:1645 E:1648 ||| IN
the  ||| S:1648 E:1652 ||| DT
following  ||| S:1652 E:1662 ||| JJ
phases ||| S:1662 E:1668 ||| NNS
.  ||| S:1668 E:1670 ||| .
Muscle  ||| S:1670 E:1677 ||| NN
enzymes  ||| S:1677 E:1685 ||| NNS
and  ||| S:1685 E:1689 ||| CC
Cr  ||| S:1689 E:1692 ||| NNP
were  ||| S:1692 E:1697 ||| VBD
directly  ||| S:1697 E:1706 ||| RB
related  ||| S:1706 E:1714 ||| VBN
to  ||| S:1714 E:1717 ||| TO
the  ||| S:1717 E:1721 ||| DT
distance  ||| S:1721 E:1730 ||| NN
covered ||| S:1730 E:1737 ||| VBN
.  ||| S:1737 E:1739 ||| .
Selected  ||| S:1739 E:1748 ||| VBN
biochemical  ||| S:1748 E:1760 ||| JJ
markers  ||| S:1760 E:1768 ||| NNS
are  ||| S:1768 E:1772 ||| VBP
evident  ||| S:1772 E:1780 ||| JJ
in  ||| S:1780 E:1783 ||| IN
some  ||| S:1783 E:1788 ||| DT
endurance  ||| S:1788 E:1798 ||| JJ
horses  ||| S:1798 E:1805 ||| NNS
before  ||| S:1805 E:1812 ||| IN
their  ||| S:1812 E:1818 ||| PRP$
elimination ||| S:1818 E:1829 ||| NN
.  ||| S:1829 E:1831 ||| .
However ||| S:1831 E:1838 ||| RB
,  ||| S:1838 E:1840 ||| ,
most  ||| S:1840 E:1845 ||| JJS
horses  ||| S:1845 E:1852 ||| NNS
developed  ||| S:1852 E:1862 ||| VBD
metabolic  ||| S:1862 E:1872 ||| JJ
disturbances  ||| S:1872 E:1885 ||| NNS
without  ||| S:1885 E:1893 ||| IN
any  ||| S:1893 E:1897 ||| DT
important  ||| S:1897 E:1907 ||| JJ
alterations  ||| S:1907 E:1919 ||| NN
in  ||| S:1919 E:1922 ||| IN
the  ||| S:1922 E:1926 ||| DT
variables  ||| S:1926 E:1936 ||| NNS
determined  ||| S:1936 E:1947 ||| VBN
in  ||| S:1947 E:1950 ||| IN
this  ||| S:1950 E:1955 ||| DT
study ||| S:1955 E:1960 ||| NN
.  ||| S:1960 E:1962 ||| .
Analysis  ||| S:1962 E:1971 ||| NN
of  ||| S:1971 E:1974 ||| IN
selected  ||| S:1974 E:1983 ||| JJ
plasma  ||| S:1983 E:1990 ||| JJ
biochemical  ||| S:1990 E:2002 ||| JJ
parameters  ||| S:2002 E:2013 ||| NNS
could  ||| S:2013 E:2019 ||| MD
be  ||| S:2019 E:2022 ||| VB
useful  ||| S:2022 E:2029 ||| JJ
in  ||| S:2029 E:2032 ||| IN
the  ||| S:2032 E:2036 ||| DT
prevention  ||| S:2036 E:2047 ||| NN
and  ||| S:2047 E:2051 ||| CC
early  ||| S:2051 E:2057 ||| JJ
diagnosis  ||| S:2057 E:2067 ||| NN
of  ||| S:2067 E:2070 ||| IN
metabolic  ||| S:2070 E:2080 ||| JJ
stress  ||| S:2080 E:2087 ||| NN
in  ||| S:2087 E:2090 ||| IN
endurance  ||| S:2090 E:2100 ||| JJ
horses ||| S:2100 E:2106 ||| NNS
.  ||| S:2106 E:2108 ||| .
